Differential regulation of E2F transcription factors by p53 tumor suppressor protein

DNA and Cell Biology

Volumn 18, Issue 12, 1999, Pages 911-922

  Vaishnav, Yashwantrai N ^a,b   Pant, Vinod ^a,c  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b LLP   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; GROWTH INHIBITION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; E2F5 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; MAMMALIA;

EID: 0033375265     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999314773     Document Type: Article

References (65)

1. ADAMS, P.A., and KAELIN, W.G., Jr. (1996). The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 208, 79-93.
2. AUSBEL, P.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1989). Current Protocols in Molecular Biology. (John Wiley, New York) pp. 7.0.1-7.6.5.
3. BANDARA, L.R., BUCK, V.M., ZAMANIAN, M., JOHNSTON, L.H., and LA THANGUE, N.B. (1993). Functional synergy between DP-1 and E2F-1 in the cell cycle regulating transcription factor DRTF1/E2F. EMBO J. 12, 4317-4324.
4. BEIJERSBERGEN, R.L., KERKHOVEN, R., ZHU, L., CARLEE, L., VOORHOEVE, P.M., and BERNARDS, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
5. BLAKE, M.C., and AZIZKHAN, J.C. (1989). Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
6. BUCHERT, M., SCHNEIDER, S., ADAMS, M.T., HEFTI, H.P., MOELLING, K., and HOVENS, C.M. ( 1997). Useful vectors for the two-hybrid system in mammalian cells. BioTechniques 23, 396-402.
7. BUCK, V., ALLEN, K.E., SORENSEN, T., BYBEE, A., HUMANS, E.M., VOORHOEVE, P.M., BERNARDS, R., and LA THANGUE, N.B. (1995). Molecular and functional characterization of E2F-5, a new member of the E2F family. Oncogene 11, 31-38.
8. CAELLES, C., HELMBERG, A., and KARIN, M. (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
9. CHEN, X., KO, L.J., JAYARAMAN, L., and PRIVES, C. (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2483-2451.
10. CRESS, W.D., and NEVINS, J.R. (1994). Interacting domains of E2F1, DP1, and the adenovirus E4 protein. J. Virol. 68, 4212-4219.
11. DANOVA, M., GIORDANO, M., MAZZINI, G., and RICCARDI, A. (1990). Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leukemia Res. 14, 417-422.
12. DEL SAL, G.D., RUARO, E.M., UTRERA, R., COLE, C.N., LEVINE, A.J., and SCHNEIDER, C. (1995). Gas1-induced growth suppression requires a transactivation-independent p53 function. Mol. Cell. Biol. 15, 7152-7160.
13. EL-DIERY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W., and VOGELSTEIN, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
14. GINSBERG, D., VAIRO, G., CHITTENDEN, T., XIAO, Z.-X., XU, G., WYDNER, K.L., DECAPRIO, J.A., LAWRENCE, J.B., and LIVINGSTON, D.M. (1994). E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8, 2665-2679.
15. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K., and ELLEDGE, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
16. HAUPT, Y., ROWAN, S., and OREN, M. (1995a). p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10, 1563-1571.
17. HAUPT, Y., ROWAN, S., SHAULIAN, E., VOUSDEN, K., and OREN, M. (1995b). Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170-2183.
18. HELIN, K. (1998). Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8, 28-35.
19. HELIN, K., HARLOW, E., and FATTAEY, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508.
20. HELIN, K., WU, C., FATTAEY, A.R., LEES, J.A., DYNLACHT, B.D., NGWU, C., and HARLOW, E. (1993). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7, 1850-1861.
21. HIJMANS, E.M., VOORHOEVE, P.M., BEIJERSBERGEN, R.L., van't VEER, L.J., and BERNARDS, R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089.
22. IKEDA, M., JAKOI, L., and NEVINS, J.R. (1996). A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 8-13.
23. JEFFREY, P.D., GORINA, S., and PAVLETICH, N.P. (1995). Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267, 1498-1502.
24. JOHNSON, D.G., CRESS, W., JAKOI, L., and NEVINS, J.R. (1994). Oncogenic capacity of the E2F-1 gene. Proc. Natl. Acad. Sci. USA 91, 12823-12827.
25. JOHNSON, D.G., SCHWARZ, J.K., CRESS, W.D., and NEVINS, J.R. (1993). Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature 365, 349-352.
26. KAELIN, W.G., JR., KREK, W., SELLERS, W.R., DECAPRIO, J.A., AJCHENBAUM, F., FUCHS, C.S., CHITTENDEN, T., LI, Y., FARNHAM, P.J., BLANAR, M.A., LIVINGSTON, D.M., and FLEMINGTON, E.K. (1992). Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364.
27. KARLSEDER, J., ROTHENEDER, H., and WINTERSBERGER, E. (1996). Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16, 1659-1667.
28. KASTAN, M.B., ONYKWERE, O., SIDRANSKY, D., VOGELSTEIN, B., and CRAIG, R.W. (1991). Participation of p53 in the cellular response to DNA change. Cancer Res. 51, 6304-6311.
29. KERN, S.E., KINZLER, K.W., BRUSKIN, A., JAROSZ, D., FRIEDMAN, P., PRIVES, C., and VOGELSTEIN, B. (1991). Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
30. KIM, Y.K., and LEE, A.S. (1991). Identification of a 70-base pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors. Mol. Cell. Biol. 10, 2296-2302.
31. KO, L.J., and PRIVES, C. (1996). p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072.
32. KREK, W., EWEN, M.E., SHIRODKAR, S., ARANY, Z., KAELIN, W.G., JR., and LIVINGSTON, D.M. (1994). Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172.
33. KREK, W., LIVINGSTON, D.M., and SHIRODKAR, S. (1993). Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262, 1557-1560.
34. LEES, J.A., SAITO, M., VIDAL, M., VALENTINE, M., LOOK, T., HARLOW, E., DYSON, N., and HELIN, K. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
35. LEVINE, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
36. LIN, J., CHEN, J., ELENBAAS, B., and LEVINE, A.J. (1994). Several hydrophobia amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235-1246.
37. LIN, S.Y., BLACK, A.R., KOSTIE, D., PAJOVIC, S., HOOVER, C.N., and AZIZKHAN, J.C. (1996). Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16, 1668-1675.
38. LINDEMAN, G.J., GAUBATZ, S., LIVINGSTON, D.M., and GINSBERG, D. (1997). The subcellular localization of E2F-4 is cell cycle dependent. Proc. Natl. Acad. Sci. USA 94, 5095-5100.
39. INK4-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057.
40. MIETZ, J.A., UNGER, T., HUIBREGTSE, J.M., and HOWLEY, P.M. (1992). The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11, 5013-5020.
41. MOBERG, K., STARZ, M.A., and LEES, J.A. (1996). E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16, 1436-1449.
42. MULLER, H., MORONI, M.C., VIGO, E., PETERSON, B.O., BARTEK, J., and HELIN, K. (1997). Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17, 5508-5520.
43. NELSON, W.G., and KASTAN, M.B. (1994). DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14, 1815-1823.
44. O'CONNOR, D.J., LAM, E.W.-F., GRIFFIN, S., ZHONG, S., LEIGHTON, L.C., BURBIDGE, S.A., and LU, X. (1995). Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14, 6184-6192.
45. PEARSON, B.E., NASHEUER, H.-P., and WANG, T.S.-F. (1991). Human DNA polymerase a gene: Sequences controlling expression in cycling and serum stimulated cells. Mol. Cell. Biol. 11, 2081-2095.
46. QIN, X.-Q., LIVINGSTON, D.M., KAELIN, W.G., JR., and ADAMS, P. (1994). Deregulated E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
47. SABBATINI, P., LIN, J., LEVINE, A.J., and WHITE, E. (1995). Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9, 2184-2192.
48. SADOWSKI, I., MA, J., TRIEZENBERG, S., and PTASHNE, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
49. SADOWSKI, I., and PTASHNE, M. (1989). A vector for expressing GAL4 (1-147) fusions in mammalian cells. Nucleic Acids Res. 17, 7539.
50. SARDET, C., LECAM, L., FABRIZIO, E., and VIDAL, M. (1997). E2Fs and the retinoblastoma protein family. In M. Yaniv, and J. Ghysdael, eds. Oncogenes as Transcriptional Regulators, vol 2: Cell Cycle Regulators and Chromosomal Translocation. (Birkhauser Verlag, Basel, Switzerland) pp. 1-62.
51. SARDET, C., VIDAL, M., COBRINIK, D., GENG, Y., ONUFRYK, C., CHEN, A., and WEINBERG, R.A. (1995). E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
52. SHAN, B., and LEE, W.-H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173.
53. SINGH, P., WONG, S., and HONG, W. ( 1994). Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329-3338.
54. SORENSEN, T.S., GIRLING, R., LEE, C.-W., GANNON, J., BANDARA, L.R., and LATHANGUE, N.B. (1996). Functional interaction between DP-1 and p53. Mol. Cell. Biol. 16, 5888-5895.
55. UNGER, T., MIETZ, J.A., SCHEFFNER, M., YEE, C.L., and HOWLEY, P.M. (1993). Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol. 13, 5186-5194.
56. VAIRO, G., LIVINGSTON, D.M., and GINSBERG, D. (1995). Functional interaction between E2f-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881.
57. VAISHNAV, Y.N., VAISHNAV, M.Y., and PANT, V. (1998). The molecular and functional characterization of E2F-5 transcription factor. Biochem. Biophys. Res. Commun. 242, 586-592.
58. VASAVADA, H., GANGULY, S., CHORNEY, M., MATHUR, R., SHUKLA, H., SWAROOP, A., and WEISSMAN, S.M. (1990). pSH4: A mammalian cDNA expression vector. Nucleic Acids Res. 18, 3668.
59. VERONA, R., MOBERG, K., ESTES, S., STARZ, M., VERNON, J.P., and LEES, J.A. (1997). E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17, 7268-7282.
60. waf1/cip1. Genes Dev. 8, 2817-2830.
61. WU, C.L., ZUKERBERG, L.R., NGWU, C., HARLOW, E., and LEES, J.A. (1995). In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15, 2536-2546.
62. WU, X., and LEVINE, A.J. (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602-3606.
63. XIAONG, Y., HANNON, G.J., ZHANG, H., CASSO, D., KOBAYASHI, R., and BEACH, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
64. XU, G., LIVINGSTON, D.M., and KREK, W. (1995). Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357-1361.
65. YONISH-ROUCH, E., BORDE, J., GOTTELAND, M., MISHAL, Z., VIRON, A., and MAY, E. (1994). Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Death Diff. 1, 39-47.